Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 3/2012

Content (20 Articles)

Effects on platelet function of a direct acting antagonist of coagulation factor Xa

Sukit M. Ringwala, Peter M. DiBattiste, David J. Schneider

Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers

Antonio Tello-Montoliu, Fabiana Rollini, Bhaloo Desai, Giuseppe Pasqualino, Ronakkumar Patel, Alexandra Santana Sorensen, Kjell S. Sakariassen, Dominick J. Angiolillo

Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulation

Sophie Gerkens, Jeannine Gailly, Caroline Obyn, Stephan Devriese, Irina Cleemput

The in vitro effects of verbascoside on human platelet aggregation

Gianluca Campo, Jlenia Marchesini, Laura Bristot, Monia Monti, Stefania Gambetti, Rita Pavasini, Alberto Pollina, Roberto Ferrari

Biomarkers of deep venous thrombosis

Huacheng Hou, Zhijuan Ge, Pu Ying, Jin Dai, Dongquan Shi, Zhihong Xu, Dongyang Chen, Qing Jiang

Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy

Giuseppe Lippi, Emmanuel J. Favaloro, Massimo Franchini

Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden

Bengt Zöller, Xinjun Li, Jan Sundquist, Kristina Sundquist

The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis

Ipek Yonal, Binnur Pinarbası, Fehmi Hindilerden, Veysel Sabri Hancer, Meliha Nalcaci, Sabahattin Kaymakoglu, Reyhan Diz-Kucukkaya

A case of IVC filter thrombosis

Kamil Muhyieddeen, Wei Chung Chen, Joseph Varon

The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia

Alexandra Bôžiková, Dana Gabriková, Adriana Sovičová, Regina Behulová, Soňa Mačeková, Iveta Boroňová, Eva Petrejčíková, Miroslav Soták, Jarmila Bernasovská, Ivan Bernasovský

Systemic thrombolysis for acute, severe Budd-Chiari syndrome

Paul J. Clark, Richard E. Slaughter, Dorothy J. Radford

Letter to the Editor

Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura

Luca A. Lotta, Ilaria Mancini, Giacomo Tuana, Khaled M. Musallam, Flora Peyvandi

Diagnosis and endovascular treatment of acute thromboembolic renal artery occlusion presenting with abdominal pain

Abdurrahim Dusak, Nalan Y. Eryilmaz, Aysun Gonen, Bahattin Hakyemez, Kamil Dilek, Cuneyt Erdogan

Coronary embolism and calcified aortic valve: is there a correlation?

Rodolfo Staico, Luciana Armaganijan, Renato D. Lopes

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine